The top-notch speaking faculty includes government perspectives from the U.S. Government Accountability Office, U.S. Public Health Service (PHS), the Department of Veterans Affairs, and the Apexus/340B Prime Vendor Program. (Timely!) Industry insights will come from Amneal, Boehringer Ingelheim, Cornerstone Therapeutics, Horizon Pharma, Johnson and Johnson, Lilly, Pfizer, and Teva.
Drug Channels readers can register with promo code HBG345 by September 13 and save $300 on registration!
OFFICIAL DESCRIPTION FROM CBI
Stay Current on Processes and Requirements of the VA, DoD and PHS and Achieve Contracting Excellence with the “Big Four” Federal Programs
Contracting with the Big Four Federal Programs can be very complex. Pricing models and processes for complying with complicated rules and regulations are difficult for any manufacturer to master. The VA DoD PHS Federal Pricing and Contracts meeting is a must-attend to stay up to date on processes and requirements and to gain best practices from your industry counterparts. Learn how to stay profitable in this low-margin, high-complexity market.
Topics to be addressed include:
- Changing VA/DoD Structure
- Introduction of Federal Qualified Health Centers (FQHCs)
- VA’s Oncology Task Force – Moving Towards Oncology Pathways
- 340B Program Changes and Recalculations
- Minimizing Loss of Profitability with Government Contracting
You will benefit from attending this event if you are a senior-level executive at a pharmaceutical or biotech company with responsibilities or involvement in the following areas:
- Government Affairs
- National Accounts
- Business Development & Strategy
- Medicaid, Medicare